Neutralizing antibody responses assessment after vaccination in people living with HIV using a surrogate neutralization assay
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Neutralizing antibody responses assessment after vaccination in people living with HIV using a surrogate neutralization assay ; volume:25 ; number:1 ; day:10 ; month:7 ; year:2024 ; pages:1-9 ; date:12.2024
BMC immunology ; 25, Heft 1 (10.7.2024), 1-9, 12.2024
- Urheber
-
Batchi-Bouyou, Armel Landry
Djontu, Jean Claude
Ingoba, Line Lobaloba
Mougany, Jiré Séphora
Mouzinga, Freisnel Hermeland
Dollon Mbama Ntabi, Jacques
Kouikani, Franck Yannis
Christ Massamba Ndala, Arcel
Diafouka-kietela, Steve
Ampa, Raoul
Ntoumi, Francine
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12865-024-00625-z
- URN
-
urn:nbn:de:101:1-2409272103553.021770550801
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Batchi-Bouyou, Armel Landry
- Djontu, Jean Claude
- Ingoba, Line Lobaloba
- Mougany, Jiré Séphora
- Mouzinga, Freisnel Hermeland
- Dollon Mbama Ntabi, Jacques
- Kouikani, Franck Yannis
- Christ Massamba Ndala, Arcel
- Diafouka-kietela, Steve
- Ampa, Raoul
- Ntoumi, Francine
- SpringerLink (Online service)
Ähnliche Objekte (12)
A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies
Homogeneous surrogate virus neutralization assay to rapidly assess neutralization activity of anti-SARS-CoV-2 antibodies
Performance evaluation of newly developed surrogate virus neutralization tests for detecting neutralizing antibodies against SARS-CoV-2
Vaccination induces broadly neutralizing antibody precursors to HIV gp41
Kinetics and ability of binding antibody and surrogate virus neutralization tests to predict neutralizing antibodies against the SARS-CoV-2 Omicron variant following BNT162b2 booster administration
Critical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika viruses
Refined identification of neutralization-resistant CRF02_AG viruses and their sensitivity to anti-MPER neutralizing antibodies
Predicting HIV-1 broadly neutralizing antibody epitope networks using neutralization titers and a novel computational method
Author Correction: Vaccination induces broadly neutralizing antibody precursors to HIV gp41
P19-41. Full-length IMC expressing Renilla luciferase for neutralization assay using PBMC
Virus replicon particle based Chikungunya virus neutralization assay using Gaussia luciferase as readout
Systemic administration of a broadly-neutralizing IgG antibody to generate HIV-neutralization responses in breast milk
A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies
Homogeneous surrogate virus neutralization assay to rapidly assess neutralization activity of anti-SARS-CoV-2 antibodies
Performance evaluation of newly developed surrogate virus neutralization tests for detecting neutralizing antibodies against SARS-CoV-2
Vaccination induces broadly neutralizing antibody precursors to HIV gp41
Kinetics and ability of binding antibody and surrogate virus neutralization tests to predict neutralizing antibodies against the SARS-CoV-2 Omicron variant following BNT162b2 booster administration
Critical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika viruses
Refined identification of neutralization-resistant CRF02_AG viruses and their sensitivity to anti-MPER neutralizing antibodies
Predicting HIV-1 broadly neutralizing antibody epitope networks using neutralization titers and a novel computational method
Author Correction: Vaccination induces broadly neutralizing antibody precursors to HIV gp41
P19-41. Full-length IMC expressing Renilla luciferase for neutralization assay using PBMC
Virus replicon particle based Chikungunya virus neutralization assay using Gaussia luciferase as readout
Systemic administration of a broadly-neutralizing IgG antibody to generate HIV-neutralization responses in breast milk
A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies
Homogeneous surrogate virus neutralization assay to rapidly assess neutralization activity of anti-SARS-CoV-2 antibodies
Performance evaluation of newly developed surrogate virus neutralization tests for detecting neutralizing antibodies against SARS-CoV-2
Vaccination induces broadly neutralizing antibody precursors to HIV gp41
Kinetics and ability of binding antibody and surrogate virus neutralization tests to predict neutralizing antibodies against the SARS-CoV-2 Omicron variant following BNT162b2 booster administration
Critical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika viruses
Refined identification of neutralization-resistant CRF02_AG viruses and their sensitivity to anti-MPER neutralizing antibodies
Predicting HIV-1 broadly neutralizing antibody epitope networks using neutralization titers and a novel computational method
Author Correction: Vaccination induces broadly neutralizing antibody precursors to HIV gp41
P19-41. Full-length IMC expressing Renilla luciferase for neutralization assay using PBMC
Virus replicon particle based Chikungunya virus neutralization assay using Gaussia luciferase as readout